{"entity":{"type":"insider","cik":"0001421882","url":"/insider/0001421882","json_url":"/insider/0001421882.json","name":"Durrant Cameron","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2013-04-08","last":"2022-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Durrant Cameron","source":"filing","n_filings":4,"first_seen":"2013-04-08","last_seen":"2022-03-04"}],"transactions":[{"id":6615756,"accession":"0001214659-22-003623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-003623","line_url":"/filing/0001214659-22-003623#line-1","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001421882","owner_name":"Durrant Cameron","owner_display_name":"Durrant Cameron","owner_url":"/insider/0001421882","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":93600.0,"total_display":"93,600.00","total_whole":"93,600","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4796495,"accession":"0001214659-21-006640","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001214659-21-006640","line_url":"/filing/0001214659-21-006640","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001421882","owner_name":"Durrant Cameron","owner_display_name":"Durrant Cameron","owner_url":"/insider/0001421882","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81441.0,"shares_display":"81,441","price_per_share":20.639903979568032,"price_display":"20.64","price_state":"stated","total_value":1680934.42,"total_display":"1,680,934.42","total_whole":"1,680,934","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider","n_lines":3},{"id":6902658,"accession":"0001144204-14-072152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-072152","line_url":"/filing/0001144204-14-072152#line-1","is_derivative":false,"issuer_cik":"0001208261","issuer_name":"IMMUNE PHARMACEUTICALS INC","issuer_ticker":"IMNP","issuer_name_source":null,"issuer_url":"/issuer/0001208261","owner_cik":"0001421882","owner_name":"Durrant Cameron","owner_display_name":"Durrant Cameron","owner_url":"/insider/0001421882","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-03","scope":"insider"},{"id":4966914,"accession":"0001140361-13-015864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-015864","line_url":"/filing/0001140361-13-015864#line-1","is_derivative":false,"issuer_cik":"0001362703","issuer_name":"PediatRx Inc.","issuer_ticker":"PEDX","issuer_name_source":null,"issuer_url":"/issuer/0001362703","owner_cik":"0001421882","owner_name":"Durrant Cameron","owner_display_name":"Durrant Cameron","owner_url":"/insider/0001421882","role":"Director, Officer (President, CEO, CFO, Treasurer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Treasurer","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250000.0,"shares_display":"4,250,000","price_per_share":0.012,"price_display":"0.01","price_state":"stated","total_value":51000.0,"total_display":"51,000.00","total_whole":"51,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-05","filed_date":"2013-04-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001293310","name":"HUMANIGEN, INC","url":"/issuer/0001293310","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2021-06-16","last_seen":"2022-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001208261","name":"IMMUNE PHARMACEUTICALS INC","url":"/issuer/0001208261","role":"Director","n_filings":1,"first_seen":"2014-12-03","last_seen":"2014-12-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001362703","name":"PediatRx Inc.","url":"/issuer/0001362703","role":"Director, Officer (President, CEO, CFO, Treasurer), Ten percent owner","n_filings":1,"first_seen":"2013-04-08","last_seen":"2013-04-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001421882","retrieved_at":"2026-08-25T11:51:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}